Source-grounded facts extracted from Concentra Group Holdings Parent, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dr. John R. Anderson retired as Executive Vice President and Chief Medical Officer at Concentra Group Holdings Parent, Inc..
“Dr. John R. Anderson notified Concentra Group Holdings Parent, Inc. (the “Company”) of his retirement from his position as Executive Vice President and Chief Medical Officer of the Company effective as of December 31, 2026.”
Concentra Group Holdings Parent, Inc. reported full year 2026 results: revenue $2.275 billion to $2.375 billion. Guidance raised.
“Concentra raised its financial guidance for 2026. We now expect to deliver the following results: • Revenue in the range of $2.275 billion to $2.375 billion”
Concentra Group Holdings Parent, Inc. reported first quarter ended March 31, 2026 results: EPS $0.39.
“Revenue of $569.6 million, an increase of 13.7% from $500.8 million in Q1 2025”
Concentra Group Holdings Parent, Inc. shareholders approved Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-04-30 meeting.
“Proposal 3 : Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Concentra Group Holdings Parent, Inc. shareholders approved Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2026-04-30 meeting.
“Proposal 2 : Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers.”
Concentra Group Holdings Parent, Inc. shareholders approved The Election of Three Class II Directors to the Board of Directors at the 2026-04-30 meeting.
“Proposal 1 : The Election of Three Class II Directors to the Board of Directors The Company’s stockholders elected the following nominees to serve as Class II directors for a term expiring at the Company’s 2029 annual meeting of stockholders and until each of their successors is duly elected and qualified.”
Concentra Group Holdings Parent, Inc. completed an acquisition involving Pivot Occupational Health, LLC for $55 million (closed 2025-06-01).
“Pursuant to the terms of the Purchase Agreement, CHS acquired all of the outstanding equity interests of Onsite Innovations from the Seller and paid a purchase price of $55 million, subject to certain customary adjustments in accordance with the terms set forth in the Purchase Agreement. CHS financed the transaction using a combination of cash on hand and”
Concentra Group Holdings Parent, Inc. completed an acquisition involving U.S. Occmed Holdings, LLC d/b/a Nova Medical Centers for $265 million (closed 2025-03-01).
“Pursuant to the terms of the Purchase Agreement, CHS acquired all of the outstanding membership interests of Nova Medical Centers from the Sellers and paid a purchase price of $265 million, subject to certain customary adjustments in accordance with the terms set forth in the Purchase Agreement. CHS financed the transaction using a combination of cash on hand,”
Concentra Group Holdings Parent, Inc. completed a disposition involving Select Medical Holdings Corporation for special stock distribution of 104,093,503 shares of Concentra's common stock (closed 2024-11-25).
“On November 25, 2024, Select Medical Holdings Corporation (“Select”) announced that it had completed the previously announced spin-off of Concentra Group Holdings Parent, Inc. (“Concentra”) by means of a special stock distribution of 104,093,503 shares of Concentra’s common stock that had been owned by Select Medical Corporation to Select’s stockholders as of the close of business on November 18, 2024 (the “Record Date”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.